Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
出版年份 2022 全文链接
标题
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
作者
关键词
-
出版物
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 111, Issue -, Pages 109130
出版商
Elsevier BV
发表日期
2022-08-12
DOI
10.1016/j.intimp.2022.109130
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients
- (2022) Dmitri Guz et al. ACTA HAEMATOLOGICA
- TLR8 / TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins
- (2022) Martina Fejtkova et al. AMERICAN JOURNAL OF HEMATOLOGY
- IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19
- (2022) Tadamitsu Kishimoto et al. Annual Review of Immunology
- Inflammation Is Present, Persistent and More Sensitive to Proinflammatory Triggers in Celiac Disease Enterocytes
- (2022) Monia Porpora et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- P096 Store-Operated Calcium Entry Controls Innate and Adaptive Immune Cell Function in Inflammatory Bowel Disease
- (2022) M Letizia et al. Journal of Crohns & Colitis
- Identification of gene expression profiles associated with an increased risk of post-operative recurrence in Crohn’s disease
- (2022) Marjolaine Ngollo et al. Journal of Crohns & Colitis
- Systemic sclerosis in adults. Part I: Clinical features and pathogenesis
- (2022) Rebekka Jerjen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A Notch/STAT3-driven Blimp-1/c-Maf-dependent molecular switch induces IL-10 expression in human CD4+ T cells and is defective in Crohn´s disease patients
- (2022) Jonas Ahlers et al. Mucosal Immunology
- Gastroparesis in systemic sclerosis: a detailed analysis using whole-gut scintigraphy
- (2022) Brittany Adler et al. RHEUMATOLOGY
- Tofacitinib and metformin reduce the dermal thickness and fibrosis in mouse model of systemic sclerosis
- (2022) Ahmet Karatas et al. Scientific Reports
- Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis
- (2022) Maria Lorena et al. Journal of Clinical Medicine
- Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6
- (2022) Andrew W. Chung et al. npj Breast Cancer
- Dual STAT‑3 and IL‑6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL‑6/IL‑6R/STAT‑3 axis
- (2022) Anibal Méndez‑Clemente et al. ONCOLOGY REPORTS
- Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease
- (2021) Stefan Schreiber et al. GASTROENTEROLOGY
- Characterization and Function of Tumor Necrosis Factor alpha and Interleukin‐6‐Induced Osteoclasts in Rheumatoid Arthritis
- (2021) Kazuhiro Yokota et al. Arthritis & Rheumatology
- Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) François-Xavier Lescure et al. Lancet Respiratory Medicine
- Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
- (2021) Dongsheng Wang et al. Frontiers of Medicine
- The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder
- (2021) Zhila Maghbooli et al. BMC Neurology
- Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis
- (2021) Tomaž Omerzu et al. WIENER KLINISCHE WOCHENSCHRIFT
- A protective role for autophagy in vitiligo
- (2021) Emanuela Bastonini et al. Cell Death & Disease
- S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils
- (2021) Adéla Navrátilová et al. Scientific Reports
- Autoimmunity in vitiligo: Therapeutic implications and opportunities
- (2021) Binod K. Khaitan et al. AUTOIMMUNITY REVIEWS
- Role of interleukin-6 in bone destruction and bone repair in rheumatoid arthritis
- (2021) Tsutomu Takeuchi et al. AUTOIMMUNITY REVIEWS
- Evaluation of serum interleukin-6 (IL-6), IL-13, and IL-17 levels and computed tomography finding in interstitial lung disease associated with connective tissue disease patients
- (2021) Dilek Tezcan et al. CLINICAL RHEUMATOLOGY
- Metabolic Comorbidities in Vitiligo: A Brief Review and Report of New Data from a Single-Center Experience
- (2021) Andrea D’Arino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Regulation of IL-6/STAT-3/Wnt axis by nifuroxazide dampens colon ulcer in acetic acid-induced ulcerative colitis model: Novel mechanistic insight
- (2021) Fares E.M. Ali et al. LIFE SCIENCES
- Loss of Interleukin-6 Influences Transcriptional Immune Signatures and Alters Bacterial Colonization in the Skin
- (2021) Lerin R. Luckett-Chastain et al. Frontiers in Microbiology
- Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19
- (2021) Dinah V. Parums MEDICAL SCIENCE MONITOR
- SYSTEMIC SCLEROSIS‐ASSOCIATED INTERSTITIAL LUNG DISEASE: How to incorporate two Food and Drug Administration‐approved therapies in clinical practice
- (2021) Dinesh Khanna et al. Arthritis & Rheumatology
- The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells
- (2021) Lara Magni et al. Cells
- Overexpression of Lin28a Aggravates Psoriasis-Like Phenotype by Regulating the Proliferation and Differentiation of Keratinocytes
- (2021) Soyeon Jang et al. Journal of Inflammation Research
- Tocilizumab suppresses the pro-carcinogenic effects of breast cancer-associated fibroblasts through inhibition of the STAT3/AUF1 pathway
- (2021) Naif Al-Jomah et al. CARCINOGENESIS
- Epigenetic drug ameliorated type 1 diabetes via decreased generation of Th1 and Th17 subsets and restoration of self-tolerance in CD4+ T cells
- (2021) Vasu Patel et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Development of type 1 diabetes in a patient treated with anti‐interleukin‐6 receptor antibody for rheumatoid arthritis
- (2021) Eiji Kawasaki et al. Journal of Diabetes Investigation
- IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes
- (2021) Carla J. Greenbaum et al. JCI Insight
- Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
- (2021) Anna Campanati et al. Biomedicines
- Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial
- (2021) Xavier Mariette et al. Lancet Rheumatology
- Interferon-γ induces interleukin-6 production by neutrophils via the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway
- (2021) Shuhei Yoshida et al. BMC Research Notes
- Experiences and needs of children with siblings diagnosed with Type 1 diabetes: A mixed studies systematic review
- (2021) Kathlynn Kai Ling Chan et al. Journal of Pediatric Nursing-Nursing Care of Children & Families
- Rho kinase Blockade Ameliorates DSS-Induced Ulcerative Colitis in Mice Through Dual Inhibition of the NF-κB and IL-6/STAT3 Pathways
- (2020) Yifan Wang et al. INFLAMMATION
- Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials
- (2020) Ambrish Singh et al. Modern Rheumatology
- Super Critical Fluid Extracted Fatty Acids from Withania somnifera Seeds Repair Psoriasis-Like Skin Lesions and Attenuate Pro-Inflammatory Cytokines (TNF-α and IL-6) Release
- (2020) Acharya Balkrishna et al. Biomolecules
- Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
- (2020) R. Marfella et al. DIABETES & METABOLISM
- Pathophysiology of Gastroparesis Syndromes Includes Anatomic and Physiologic Abnormalities
- (2020) Thomas L. Abell et al. DIGESTIVE DISEASES AND SCIENCES
- Translating IL-6 biology into effective treatments
- (2020) Ernest H. Choy et al. Nature Reviews Rheumatology
- Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures
- (2020) Wilma Barcellini et al. Expert Review of Hematology
- Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
- (2020) Emanuel Della-Torre et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple‐negative breast cancer
- (2020) Noura N. Alraouji et al. MOLECULAR CARCINOGENESIS
- IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis
- (2020) Mario Stampanoni Bassi et al. Frontiers in Cellular Neuroscience
- Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica
- (2020) Agnieshka M. Agasing et al. Nature Communications
- Investigation of the Role of Interleukin 6 in Vitiligo Pathogenesis
- (2020) Mala Singh et al. IMMUNOLOGICAL INVESTIGATIONS
- Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6
- (2020) Ryota Tanaka et al. Communications Biology
- Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease
- (2020) Hamidreza Samaee et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
- (2020) Reza Malekzadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tocilizumab inhibits IL‐8 and the proangiogenic potential of triple negative breast cancer cells
- (2020) Noura N. Alraouji et al. MOLECULAR CARCINOGENESIS
- Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
- (2020) Belén Ruiz-Antorán et al. Infectious Diseases and Therapy
- IL-6, IL-12, and IL-23 STAT-Pathway Genetic Risk and Responsiveness of Lymphocytes in Patients with Multiple Sclerosis
- (2019) Marina von Essen et al. Cells
- Current approaches in the grading and management of cytokine release syndrome after chimeric antigen receptor T-cell therapy
- (2019) Lara L. Riegler et al. Therapeutics and Clinical Risk Management
- Targeting Interleukin-6 Signaling in Clinic
- (2019) Sujin Kang et al. IMMUNITY
- The pathogenicity of Th17 cells in autoimmune diseases
- (2019) Keiko Yasuda et al. Seminars in Immunopathology
- IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis
- (2019) A. Francesca Setiadi et al. JOURNAL OF NEUROIMMUNOLOGY
- Role and mechanism of the Th17/Treg cell balance in the development and progression of insulin resistance
- (2019) Limin Tao et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The Role of T Follicular Helper Cells and T Follicular Regulatory Cells in the Pathogenesis of Autoimmune Hemolytic Anemia
- (2019) Yuhan Gao et al. Scientific Reports
- A potential therapeutic target RNA-binding protein, Arid5a for the treatment of inflammatory disease associated with aberrant cytokine expression
- (2018) Kazuya Masuda et al. CURRENT PHARMACEUTICAL DESIGN
- Sarilumab: A Review in Moderate to Severe Rheumatoid Arthritis
- (2018) Yvette N. Lamb et al. DRUGS
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
- (2018) Robert Q. Le et al. ONCOLOGIST
- Regulation of inflammatory responses by dynamic subcellular localization of RNA-binding protein Arid5a
- (2018) Mitsuru Higa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recent Advances in Giant Cell Arteritis
- (2018) M. Guevara et al. Current Rheumatology Reports
- S100 Proteins As an Important Regulator of Macrophage Inflammation
- (2018) Chang Xia et al. Frontiers in Immunology
- IL-6 signalling pathways and the development of type 2 diabetes
- (2018) Mohamad Akbari et al. INFLAMMOPHARMACOLOGY
- MicroRNA let-7b inhibits keratinocyte differentiation by targeting IL-6 mediated ERK signaling in psoriasis
- (2018) Yan Wu et al. Cell Communication and Signaling
- Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1
- (2018) Aleksandra Maria Dufour et al. Frontiers in Immunology
- Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What’s the Difference?
- (2018) Ali Berkant Avci et al. BIODRUGS
- MicroRNA-217 regulates interstitial pneumonia via IL-6
- (2018) Jiongwei Pan et al. BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
- Molecular and functional heterogeneity of IL-10-producing CD4+ T cells
- (2018) Leonie Brockmann et al. Nature Communications
- Inhibition of HMGB1 reduces rat spinal cord astrocytic swelling and AQP4 expression after oxygen-glucose deprivation and reoxygenation via TLR4 and NF-κB signaling in an IL-6-dependent manner
- (2017) Lin Sun et al. Journal of Neuroinflammation
- The role of IL-6 in host defence against infections: immunobiology and clinical implications
- (2017) Stefan Rose-John et al. Nature Reviews Rheumatology
- Interleukin-6 and interleukin-17 gene polymorphism association with celiac disease in children
- (2017) Ulas Emre Akbulut et al. Turkish Journal of Gastroenterology
- Interleukin-6 Family Cytokines
- (2017) Stefan Rose-John Cold Spring Harbor Perspectives in Biology
- Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
- (2017) Debomita Chakraborty et al. Nature Communications
- Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation
- (2017) Steffen Riethmueller et al. PLOS BIOLOGY
- IL-6 promotes the differentiation of a subset of naive CD8 + T cells into IL-21–producing B helper CD8 + T cells
- (2016) Rui Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
- (2016) Sylvia Heink et al. NATURE IMMUNOLOGY
- Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression
- (2016) Christian Hundhausen et al. Science Translational Medicine
- Formulary Review of 2 New Biologic Agents: Tocilizumab for Rheumatoid Arthritis and Ustekinumab for Plaque Psoriasis
- (2016) Jeremy A. Schafer et al. JOURNAL OF MANAGED CARE PHARMACY
- A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
- (2015) E. M. Dijkgraaf et al. ANNALS OF ONCOLOGY
- Regnase-1 and Roquin Regulate a Common Element in Inflammatory mRNAs by Spatiotemporally Distinct Mechanisms
- (2015) Takashi Mino et al. CELL
- Interleukin-6 as a Therapeutic Target
- (2015) J.-F. Rossi et al. CLINICAL CANCER RESEARCH
- Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues
- (2015) Gareth W. Jones et al. IMMUNOLOGY
- Association of interleukin-6 gene polymorphism with coronary artery disease: an updated systematic review and cumulative meta-analysis
- (2015) Haifeng Hou et al. INFLAMMATION RESEARCH
- Versatile functions for IL-6 in metabolism and cancer
- (2015) Jan Mauer et al. TRENDS IN IMMUNOLOGY
- Clinical Development of Siltuximab
- (2015) Christine C. Davis et al. Current Oncology Reports
- Anti-proliferative action of IL-6R-targeted antibody tocilizumab for non-small cell lung cancer cells
- (2015) NA-HYUN KIM et al. Oncology Letters
- Siltuximab: First Global Approval
- (2014) Anthony Markham et al. DRUGS
- Regulation of the Interleukin-6 gene expression during monocytic differentiation of HL-60 cells by chromatin remodeling and methylation
- (2014) Magdalena K. Poplutz et al. IMMUNOBIOLOGY
- Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer
- (2014) Lanxi Song et al. Journal of Thoracic Oncology
- IL-6 biology: implications for clinical targeting in rheumatic disease
- (2014) Leonard H. Calabrese et al. Nature Reviews Rheumatology
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies
- (2014) Joanna Kitley et al. JAMA Neurology
- Inflammation and prostate cancer: the role of interleukin 6 (IL-6)
- (2013) Daniel P. Nguyen et al. BJU INTERNATIONAL
- Cutting Edge: STAT1 Is Required for IL-6-Mediated Bcl6 Induction for Early Follicular Helper Cell Differentiation
- (2013) Y. S. Choi et al. JOURNAL OF IMMUNOLOGY
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo
- (2013) Kazuya Masuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tocilizumab in rheumatoid arthritis: efficacy, safety and its place in therapy
- (2013) Atsushi Kaneko Therapeutic Advances in Chronic Disease
- Plasticity and cross-talk of Interleukin 6-type cytokines
- (2012) Christoph Garbers et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The biology and mechanism of action of suppressor of cytokine signaling 3
- (2012) Jeffrey J. Babon et al. GROWTH FACTORS
- A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer
- (2012) Gary Hudes et al. INVESTIGATIONAL NEW DRUGS
- The origins, function, and regulation of T follicular helper cells
- (2012) Cindy S. Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-6 deficiency exacerbates skin inflammation in a murine model of irritant dermatitis
- (2012) Eric G. Lee et al. Journal of Immunotoxicology
- Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis
- (2012) Shumpei Yokota et al. Therapeutic Advances in Musculoskeletal Disease
- Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma
- (2011) Shun Kitaba et al. AMERICAN JOURNAL OF PATHOLOGY
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
- (2011) Trevor J Bayliss et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma
- (2011) Satoru Shinriki et al. JOURNAL OF PATHOLOGY
- Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
- (2011) Norio Chihara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study
- (2011) Jayaprakash Karkera et al. PROSTATE
- A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
- (2010) J-F Rossi et al. BRITISH JOURNAL OF CANCER
- Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
- (2010) Y. Guo et al. CLINICAL CANCER RESEARCH
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tocilizumab for the treatment of rheumatoid arthritis
- (2010) Toshio Tanaka et al. Expert Review of Clinical Immunology
- Tocilizumab
- (2010) Adith Venkiteshwaran mAbs
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir
- (2010) Toshio HIRANO PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
- (2009) Kenneth L. Becker et al. CRITICAL CARE MEDICINE
- Tocilizumab
- (2009) Vicki Oldfield et al. DRUGS
- Tocilizumab
- (2009) Clemens Scheinecker et al. NATURE REVIEWS DRUG DISCOVERY
- The role of Toll-like receptors in rheumatoid arthritis
- (2009) Qi-Quan Huang et al. Current Rheumatology Reports
- Tocilizumab: An lnterleukin-6 Receptor Inhibitor for the Treatment of Rheumatoid Arthritis
- (2008) Susyn L Plushner ANNALS OF PHARMACOTHERAPY
- Systematic review of the association between circulating interleukin-6 (IL-6) and cancer
- (2008) Katriina Heikkilä et al. EUROPEAN JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started